RedHill Biopharma Ltd. (RDHL) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

RedHill Biopharma Ltd. (RDHL) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $2.1M, listed on NASDAQ, employing roughly 13 people, carrying a beta of 4.90 to the broader market. RedHill Biopharma Ltd. Led by Dror Ben-Asher, public since 2013-01-07.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for RDHL as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →